Odawara, Japan

Kunitomo Suzuki

This inventor holds 2 USPTO granted patents. Top assignee: Lion Corporation. Active years: 1984-1990.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 49(Granted Patents)


Location History:

  • Hatano, JP (1984)
  • Odawara, JP (1990)

Company Filing History:


Years Active: 1984-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kunitomo Suzuki: Innovator in Dental Adhesives and Antitumor Compounds

Introduction

Kunitomo Suzuki is a notable inventor based in Odawara, Japan. He has made significant contributions to the field of dental adhesives and pharmaceutical compounds. With a total of 2 patents to his name, his work has implications for both dental health and cancer treatment.

Latest Patents

Suzuki's latest patents include a dental adhesive composition that features a unique compound formula. This innovative adhesive is designed to enhance the bonding process in dental applications. Additionally, he has developed novel 1-phenyl-1H-pyrazolo[3,4-b]pyrazine derivatives. These derivatives are characterized by their antitumor and antiviral activity, showcasing their potential in medical treatments.

Career Highlights

Kunitomo Suzuki is associated with Lion Corporation, a company known for its commitment to quality and innovation in consumer products. His work at Lion Corporation has allowed him to focus on developing advanced materials that can improve health outcomes.

Collaborations

Throughout his career, Suzuki has collaborated with esteemed colleagues such as Shinya Kitoh and Hiromitsu Honda. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Kunitomo Suzuki's contributions to dental adhesives and antitumor compounds highlight his role as a significant inventor in his field. His innovative work continues to impact both dental and medical industries positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…